Socialization of corner care in newborn babies as an efforts to prevent infections in the corner at PMB Ernita Pekanbaru
DOI:
https://doi.org/10.59247/jppmi.v1i3.14Keywords:
Umbilical cord care, Newborns, Infection preventionAbstract
The umbilical cord or in medical terms known as the umbilical funiculus is a lifeline for the fetus during the womb. Caring for the umbilical cord is also important to prevent neonatal tetanus, which can cause death. The body of a newborn baby is not strong enough to ward off infectious germs. Based on the results of the survey, it was found that mothers who had babies aged 0-7 days did the wrong umbilical cord care. Of the 5 pregnant women found, 2 of them still use spices (turmeric) to speed up the delivery of the umbilical cord. In PMB Ernita in the last 6 months has never done any counseling related to umbilical cord care. So it is necessary to carry out activities to overcome the problems found through the socialization of umbilical cord care for mothers. The target of this activity is to increase knowledge about proper umbilical cord care so that it can change the mother's behavior in caring for the newborn's umbilical cord. The results of this activity will be published in the community service journal of Muhammadiyah University of Riau. This activity was carried out in 2 stages: 1. Counseling was carried out on November 16, 2020, 2. The stage of coaching, monitoring and evaluation was carried out for 1 week with home visits from November 23 - 29 2020. The results of this activity were 1) Increased knowledge of mothers who have a baby about the correct care of the umbilical cord is seen from the ability of the baby's mother in answering the questions posed by the speaker, of the 10 questions given by the speaker can be answered by the baby's mother. 2) Increasing the skills of the baby's mother in properly caring for her own umbilical cord, so that it is possible for participants to apply these skills in daily life. This can be seen when the service team makes home visits. It is hoped that health workers in this case midwives can prepare postpartum mothers in caring for newborns, especially umbilical cord care starting from pregnancy.
References
C.-W. Chien, K.-J. Chen, J.-Y. Lai, and A.-S. Chao, “Patent urachus or bladder exstrophy occulta? A case of prenatally disappeared umbilical cord cyst,” Urol. Case Reports, vol. 39, p. 101772, Nov. 2021, doi: 10.1016/j.eucr.2021.101772.
M. A. Knovich, “Chains of Iron in Umbilical Cord Blood Hematopoietic Stem Cell Transplantation: Comment on ‘Iron Overload Is Associated with Delayed Engraftment and Increased Nonrelapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell Transplantation’ b,” Biol. Blood Marrow Transplant., vol. 26, no. 9, pp. e213–e214, Sep. 2020, doi: 10.1016/j.bbmt.2020.07.012.
L. Huilan et al., “Low-Dose Methotrexate Could Reduce Severe Early Immune Reactions but Probably Increase Garft Failure in Umbilical Cord Blood Transplantation,” Blood, vol. 134, pp. 5679–5679, Nov. 2019, doi: 10.1182/blood-2019-131524.
X. Fang, Z. Sun, H. Liu, and L. Xia, “Donor KIR3DL1/Receptor HLA-Bw4-80I Combination Reduce Acute Leukemia Relapse after Umbilical Cord Blood Transplantation without in Vitro T-Cell Depletion,” Blood, vol. 132, pp. 3420–3420, Nov. 2018, doi: 10.1182/blood-2018-99-117775.
S. A. Patel et al., “Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience,” Biol. Blood Marrow Transplant., vol. 23, no. 10, pp. 1722–1728, Oct. 2017, doi: 10.1016/j.bbmt.2017.06.013.
K. W. Su et al., “Cord blood soluble Fas ligand linked to allergic rhinitis and lung function in seven-year-old children,” J. Microbiol. Immunol. Infect., vol. 55, no. 2, pp. 300–306, Apr. 2022, doi: 10.1016/J.JMII.2021.03.016.
Y.-J. Kim, H.-J. Ahn, S.-H. Lee, M.-H. Lee, and K.-S. Kang, “Effects of conditioned media from human umbilical cord blood-derived mesenchymal stem cells in the skin immune response,” Biomed. Pharmacother., vol. 131, p. 110789, Nov. 2020, doi: 10.1016/j.biopha.2020.110789.
M. Di Tommaso et al., “Evaluation of umbilical cord pulsatility after vaginal delivery in singleton pregnancies at term,” Eur. J. Obstet. Gynecol. Reprod. Biol., vol. 236, pp. 94–97, May 2019, doi: 10.1016/j.ejogrb.2019.03.008.
P. Sharma et al., “Post Transplant Prophylaxis with High Dose Valacyclovir through Day 100 Versus Day of Post Transplant Hospital Discharge Decreases Cytomegalovirus Reactivation in Adult Umbilical Cord Blood Transplant Recipients,” Blood, vol. 132, pp. 4659–4659, Nov. 2018, doi: 10.1182/blood-2018-99-110211.
I. Politikos et al., “Angiogenic Factors Correlate with T Cell Immune Reconstitution and Clinical Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults,” Biol. Blood Marrow Transplant., vol. 23, no. 1, pp. 103–112, Jan. 2017, doi: 10.1016/j.bbmt.2016.10.013.
O. Andersson and J. S. Mercer, “Cord Management of the Term Newborn,” Clin. Perinatol., vol. 48, no. 3, pp. 447–470, Aug. 2021, doi: 10.1016/j.clp.2021.05.002.
C. C. Pedrosa de Lira de Morais, J. Dias Alves Pinto, K. Wagner de Souza, M. Izu, L. Fernando da Silva Bouzas, and F. Henrique Paraguassú-Braga, “Validation of the single-platform ISHAGE protocol for enumeration of CD34+ hematopoietic stem cells in umbilical cord blood in a Brazilian center,” Hematol. Transfus. Cell Ther., vol. 44, no. 1, pp. 49–55, Mar. 2022, doi: 10.1016/J.HTCT.2020.09.151.
L. R. Braid, C. A. Wood, and B. N. Ford, “Human umbilical cord perivascular cells: A novel source of the organophosphate antidote butyrylcholinesterase,” Chem. Biol. Interact., vol. 305, pp. 66–78, May 2019, doi: 10.1016/j.cbi.2019.03.022.
J. A. Hill et al., “A Modified Intensive Strategy to Prevent Cytomegalovirus Disease in Seropositive Umbilical Cord Blood Transplantation Recipients,” Biol. Blood Marrow Transplant., vol. 24, no. 10, pp. 2094–2100, Oct. 2018, doi: 10.1016/j.bbmt.2018.05.008.
J. Tong et al., “Umbilical Cord Blood Transplantation without Antithymocyte Globulin Results in Similar Survival but Better Quality of Life Compared with Unrelated Peripheral Blood Stem Cell Transplantation for the Treatment of Acute Leukemia—A Retrospective Study in Chin,” Biol. Blood Marrow Transplant., vol. 23, no. 9, pp. 1541–1548, Sep. 2017, doi: 10.1016/j.bbmt.2017.05.004.
H. He, T. Yang, F. Li, L. Zhang, and X. Ling, “A novel study on the immunomodulatory effect of umbilical cord derived mesenchymal stem cells pretreated with traditional Chinese medicine Asarinin,” Int. Immunopharmacol., vol. 100, p. 108054, Nov. 2021, doi: 10.1016/j.intimp.2021.108054.
W. Tong et al., “Multiple umbilical cord–derived MSCs administrations attenuate rat osteoarthritis progression via preserving articular cartilage superficial layer cells and inhibiting synovitis,” J. Orthop. Transl., vol. 23, pp. 21–28, Jul. 2020, doi: 10.1016/j.jot.2020.03.007.
J. L. Leante Castellanos et al., “Recommendations for the care of the umbilical cord in the newborn,” An. Pediatría (English Ed., vol. 90, no. 6, pp. 401.e1-401.e5, Jun. 2019, doi: 10.1016/j.anpede.2019.01.009.
T. C. Lund, “Umbilical Cord Blood Expansion: Are We There Yet?,” Biol. Blood Marrow Transplant., vol. 24, no. 7, pp. 1311–1312, Jul. 2018, doi: 10.1016/j.bbmt.2018.05.002.
S. Anand et al., “Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization,” Biol. Blood Marrow Transplant., vol. 23, no. 7, pp. 1151–1157, Jul. 2017, doi: 10.1016/j.bbmt.2017.04.001.
U. Ibrahim and A. Keyzner, “Autoimmune hematologic complications of umbilical cord blood transplantation,” Hematol. Oncol. Stem Cell Ther., vol. 14, no. 2, pp. 104–109, 2021, doi: 10.1016/j.hemonc.2020.07.009.
S. Terakura et al., “Prospective Phase 2 Study of Umbilical Cord Blood Transplantation in Adult Acute Leukemia and Myelodysplastic Syndrome,” Biol. Blood Marrow Transplant., vol. 26, no. 1, pp. 139–144, Jan. 2020, doi: /10.1016/j.bbmt.2019.09.021.
T. Ochi et al., “Umbilical Cord Blood Transplantation Using Reduced-Intensity Conditioning without Antithymocyte Globulin in Adult Patients with Severe Aplastic Anemia,” Biol. Blood Marrow Transplant., vol. 25, no. 2, pp. e55–e59, Feb. 2019, doi: 10.1016/j.bbmt.2018.09.039.
F. Liu, X. Zhu, Y. Guo, X. Chen, and M. Ruan, “Successful Umbilical Cord Blood Transplantation in Relapsed B-Cell Acute Lymphoblastic Leukemia after Chimeric Antigen Receptors Therapy,” Blood, vol. 132, pp. 5774–5774, Nov. 2018, doi: 10.1182/blood-2018-99-118452.
R. Einikyte et al., “The comparison of umbilical cord arterial blood lactate and pH values for predicting short-term neonatal outcomes,” Taiwan. J. Obstet. Gynecol., vol. 56, no. 6, pp. 745–749, Dec. 2017, doi: 10.1016/J.TJOG.2017.10.007.
E. Broset et al., “Engineering a new vaccine platform for heterologous antigen delivery in live-attenuated Mycobacterium tuberculosis,” Comput. Struct. Biotechnol. J., vol. 19, pp. 4273–4283, Jan. 2021, doi: 10.1016/J.CSBJ.2021.07.035.
S. R. Procter et al., “A review of the costs of delivering maternal immunisation during pregnancy,” Vaccine, vol. 38, no. 40, pp. 6199–6204, Sep. 2020, doi:. 10.1016/j.vaccine.2020.07.050.
E. Aliprandini, D. Y. Takata, A. Lepique, J. Kalil, S. B. Boscardin, and A. M. Moro, “An oligoclonal combination of human monoclonal antibodies able to neutralize tetanus toxin in vivo,” Toxicon X, vol. 2, p. 100006, Apr. 2019, doi: 10.1016/j.toxcx.2019.100006.
Moynan, R. O’Riordan, R. O’Connor, and C. Merry, “Tetanus – A Rare But Real Threat,” IDCases, vol. 12, pp. 16–17, Jan. 2018, doi: 10.1016/J.IDCR.2018.02.004.
J. Wysocki et al., “A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinations,” Vaccine, vol. 35, no. 15, pp. 1926–1935, Apr. 2017, doi: 10.1016/j.vaccine.2017.02.035.
M. Velandia-González et al., “Monitoring progress of maternal and neonatal immunization in Latin America and the Caribbean,” Vaccine, vol. 39, pp. B55–B63, Jul. 2021, doi: 10.1016/j.vaccine.2020.12.043.
G. Carrasquilla et al., “Incidence and mortality of pertussis disease in infants <12 months of age following introduction of pertussis maternal universal mass vaccination in Bogotá, Colombia,” Vaccine, vol. 38, no. 46, pp. 7384–7392, Oct. 2020, doi: 10.1016/j.vaccine.2020.07.046.
B. A. Randi et al., “Low tetanus-diphtheria-acellular pertussis (Tdap) vaccine coverage among healthcare workers in a quaternary university hospital in São Paulo, Brazil: need for continuous surveillance and implementation of active strategies,” Brazilian J. Infect. Dis., vol. 23, no. 4, pp. 231–236, Jul. 2019, doi: 10.1016/j.bjid.2019.06.007.
D. H. Huh et al., “Immunogenicity and protective efficacy of a newly developed tri-component diphtheria, tetanus, and acellular pertussis vaccine in a murine model,” J. Microbiol. Immunol. Infect., vol. 51, no. 6, pp. 732–739, Dec. 2018, doi: 10.1016/j.jmii.2017.04.003.
A. Y. Aqeel, H. M. Arishi, H. I. Ageel, and N. H. Arishi, “Epidemiological and clinical aspects of neonatal tetanus from a tertiary care hospital,” Int. J. Pediatr. Adolesc. Med., vol. 4, no. 2, pp. 71–74, Jun. 2017, doi: 10.1016/j.ijpam.2016.10.001.
G. Singh et al., “The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990–2019,” Lancet Glob. Heal., vol. 9, no. 8, pp. e1129–e1144, Aug. 2021, doi: 10.1016/S2214-109X(21)00164-9.
P. Hanvatananukul et al., “Seroprevalence of antibodies against diphtheria, tetanus, and pertussis among healthy Thai adolescents,” Int. J. Infect. Dis., vol. 96, pp. 422–430, Jul. 2020, doi: 10.1016/j.ijid.2020.04.088.
A. Strezova et al., “The adjuvanted recombinant zoster vaccine co-administered with a tetanus, diphtheria and pertussis vaccine in adults aged ≥50 years: A randomized trial,” Vaccine, vol. 37, no. 39, pp. 5877–5885, Sep. 2019, doi: 10.1016/j.vaccine.2019.08.001.
A. Kaeding, K. Tarlock, E. A. Kolb, and S. Meshinchi, “Immunotherapeutic Targeting of Mesothelin in Acute Myeloid Leukemia in Vitro with Anetumab Ravtansine and a Novel Antibody-Drug Conjugate,” Blood, vol. 132, pp. 1448–1448, Nov. 2018, doi: 10.1182/blood-2018-99-110845.
I. Toker et al., “Tetanus immunity status among adult trauma patients in an ED,” Turkish J. Emerg. Med., vol. 17, no. 3, pp. 95–98, Sep. 2017, doi: 10.1016/j.tjem.2017.02.001.
S. M. McAlister, A. H. J. van den Biggelaar, R. B. Thornton, and P. C. Richmond, “Optimising a 6-plex tetanus-diphtheria-pertussis fluorescent bead-based immunoassay,” MethodsX, vol. 8, p. 101360, 2021, doi: 10.1016/j.mex.2021.101360.
C. Leese et al., “Duplication of clostridial binding domains for enhanced macromolecular delivery into neurons,” Toxicon X, vol. 5, p. 100019, Mar. 2020, doi: 10.1016/j.toxcx.2019.100019.
E. H. Ibrahim et al., “TH1/TH2 chemokines/cytokines profile in rats treated with tetanus toxoid and Euphorbia tirucalli,” Saudi J. Biol. Sci., vol. 26, no. 7, pp. 1716–1723, Nov. 2019, doi: 10.1016/j.sjbs.2018.08.005.
F. Omeñaca et al., “Immunization of preterm infants with GSK’s hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity,” Vaccine, vol. 36, no. 7, pp. 986–996, Feb. 2018, doi: 10.1016/j.vaccine.2018.01.005.
S. B. Han et al., “Immunogenicity and safety of the new reduced-dose tetanus–diphtheria vaccine in healthy Korean adolescents: A comparative active control, double-blind, randomized, multicenter phase III study,” J. Microbiol. Immunol. Infect., vol. 50, no. 2, pp. 207–213, Apr. 2017, doi: 10.1016/j.jmii.2015.04.005.
A. S. De Groot et al., “Identification of a potent regulatory T cell epitope in factor V that modulates CD4+ and CD8+ memory T cell responses,” Clin. Immunol., vol. 224, p. 108661, Mar. 2021, doi: 10.1016/j.clim.2020.108661.
P. ONeil, A. Ladokhin, L. Swint-Kruse, and M. Baldwin, “Fluorescent Study on Tetanus Neurotoxin,” Biophys. J., vol. 118, no. 3, p. 359a, Feb. 2020, doi: 10.1016/j.bpj.2019.11.2066.
K. Bollaerts, T. Verstraeten, and C. Cohet, “Observational studies of non-specific effects of Diphtheria-Tetanus-Pertussis vaccines in low-income countries: Assessing the potential impact of study characteristics, bias and confounding through meta-regression,” Vaccine, vol. 37, no. 1, pp. 34–40, Jan. 2017, doi: 10.1016/j.vaccine.2018.11.049.
A. Fettelschoss-Gabriel et al., “Treating insect-bite hypersensitivity in horses with active vaccination against IL-5,” J. Allergy Clin. Immunol., vol. 142, no. 4, pp. 1194-1205.e3, Oct. 2018, doi: 10.1016/j.jaci.2018.01.041.
S. W. Mogensen, A. Andersen, A. Rodrigues, C. S. Benn, and P. Aaby, “The Introduction of Diphtheria-Tetanus-Pertussis and Oral Polio Vaccine Among Young Infants in an Urban African Community: A Natural Experiment,” EBioMedicine, vol. 17, pp. 192–198, Mar. 2017, doi: 10.1016/j.ebiom.2017.01.041.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Jurnal Pengabdian dan Pemberdayaan Masyarakat Indonesia
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
